Kailera Therapeutics, Inc. ($KLRA)
Filing Information
| Accession Number | 0001231919-26-000390 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 22, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
21,053,640
Total Value
$8,000,000.00
P&L
+51.9% (+$4,150,000.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock | โ | Apr 20, 2026 | Conversion | 10,276,820 | โ | โ | 10,276,820 | Indirect | See footnote | View Details | |
10% Owner | Common Stock | โ | Apr 20, 2026 | Purchase | 500,000 | $16.00 | $8,000,000.00 | 10,776,820 | Indirect | See footnote | View Details | |
10% Owner | Series A Preferred Stock | Derivative | Apr 20, 2026 | Conversion | 8,250,000 | โ | โ | 0 | Indirect | See footnote | View Details | |
10% Owner | Series B Preferred Stock | Derivative | Apr 20, 2026 | Conversion | 2,026,820 | โ | โ | 0 | Indirect | See footnote | View Details |